logo
科言猫学术研究的AI总结
language
手机端手机端
  • Phone Feature微信小程序
简体中文简体中文
notice消息通知
博客博客
arrow
Q

Qianyi Lu

Sun Yat-sen University Cancer Center
H指数:12
被引数:460

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

HDAC inhibitor tucidinostat and metronomic capecitabine plus endocrine therapy for patients with HR-positive HER2-negative advanced breast cancer after CDK4/6 inhibitors treatment: clinical findings and exploratory circulating tumor cell and ctDNA biomarker analyses of a multicenter, phase 2 study (SYSUCC-020 trial)

HDAC抑制剂tucidinostat和节拍卡培他滨联合内分泌治疗CDK4/6抑制剂治疗后HR阳性HER2-negative晚期乳腺癌患者: 一项多中心2期研究的临床发现和探索性循环肿瘤细胞和ctDNA生物标志物分析 (SYSUCC-020试验)

Signal Transduction and Targeted Therapy
IF52.7
2026-04-150
OAAI
Huai-liang Wu; Wen Xia; Zhengyang Xu; Hanxing Zhou; Limin Chen; Yongkui Lu; Xinlan Liu; Danmei Pang; Yan Liu; Qianyi Lu; Fei Xu; Xin An; Jiajia Huang; Kuikui Jiang; Jingmin Zhang; Yili Cai; Ruoxi Hong; Qiufan Zheng; Shusen Wang
NetLnc: A Network-Based Computational Framework to Identify Immune Checkpoint-Related lncRNAs for Immunotherapy Response in Melanoma

NetLnc：一种基于网络的计算框架，用于识别与黑色素瘤免疫治疗反应相关的免疫检查点相关lncRNAs

INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
IF4.9
2025-05-090
OA
Lu, Qianyi; Li, Jian; Chen, Wenli; Wang, Zhuoru; Wang, Di; Liu, Chenyu; Sun, Yue; Jiang, Han; Zhang, Caiyu; Chang, Yetong; Zhou, Jiajun; Wu, Xiaohong; Gao, Yue; Ning, Shangwei

研究方向

暂未获取到该数据
S
Shusen Wang
H 指数:39论文数:237被引数:6,515
K
Kuikui Jiang
H 指数:11论文数:63被引数:592
R
Ruoxi Hong
H 指数:19论文数:110被引数:1,607
徐飞 封面图
徐飞
H 指数:33论文数:197被引数:4,140
Q
Qiufan Zheng
H 指数:14论文数:85被引数:854
W
Wen Xia
H 指数:26论文数:130被引数:1,884
D
Danyang Zhou
H 指数:12论文数:41被引数:382
K
Kaping Lee
H 指数:13论文数:38被引数:386
史
史艳侠
H 指数:24论文数:129被引数:2,724
袁
袁中玉
H 指数:28论文数:181被引数:3,001